Cumberland Pharmaceuticals Inc.
CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment oā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.41
Price+0.69%
$0.03
1Y
Price
Market Cap
$65.962m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-9.6%
EBITDA Margin-23.4%
Net Profit Margin+2.0%
Free Cash Flow MarginRevenue
$41.278m
+9.0%
1y CAGR-0.4%
3y CAGR+3.9%
5y CAGREarnings
-$3.328m
+48.6%
1y CAGR+10.9%
3y CAGR-6.5%
5y CAGREPS
-$0.24
+47.8%
1y CAGR+9.2%
3y CAGR-7.7%
5y CAGRBook Value
$25.801m
$65.899m
Assets$40.098m
Liabilities$10.238m
DebtDebt to Assets
15.5%
3.8x
Debt to EBITDAFree Cash Flow
$6.709m
+947.3%
1y CAGR+273.9%
3y CAGR+207.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company